Total Knee Anthroplastysacral ESPNCT07017400
The Sacral Erector Spinae Plane Block in Total Knee Arthroplasty
An observational study of Total Knee Anthroplasty and Regional Anesthesia, run by San Giovanni di Dio Hospital at 1 site in Italy.
Trial summary
The goal of this observational study is to learn about the analgesic efficacy and postoperative recovery of two locoregional anesthesia combinations in patients > 18 years (ASA I-III), scheduled for unilateral TKA under spinal anesthesia with expected hospitalization > 24 hours: ACB + sacral ESP block ACB + iPACK… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Total Knee Anthroplasty, Regional Anesthesia
- What is being tested?
- Local Anesthetic Injection
- Type of treatment
- Pill or oral medicine, Injection or infusion, Surgery or procedure
- How many people
- 126 participants
- Where
- 1 siteItaly
- Study dates
- 16 Jul 2025to Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adults >18 years scheduled for unilateral TKA
Who may be able to join
- Adults >18 years
- ASA I-III
- scheduled for unilateral TKA with expected hospitalization > 24 hours
Who cannot join
- Refusal of consent
- Local anesthetics allergies
- contraindications to spinal or regional anesthesia
- coagulation disorders
- anticoagulation/antiaggregation medications
- dementia
Show all 9Show fewer
- ASA-PS > III
- ongoing infection
- emergency surgeries
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
San Giovanni Crotone Hospital
Crotone
Tommaso Sorrentino, M.D.
About this study
Official title: Effectiveness of the Sacral Erector Spinae Plane (ESP) Block in Total Knee Arthroplasty: A Prospective Observational Study
The goal of this observational study is to learn about the analgesic efficacy and postoperative recovery of two locoregional anesthesia combinations in patients > 18 years (ASA I-III), scheduled for unilateral TKA under spinal anesthesia with expected hospitalization > 24 hours:
- ACB + sacral ESP block
- ACB + iPACK block
The main question it aims to answer is: Does the ACB + sacral ESP block combination produce effective postoperative recovery and analgesic effect?
Participants already taking ACB + sacral ESP block as part of their regular peri-operative care for TKA will be followed in the postoperative period for 48 hours.
Read the detailed description
Total Knee Arthroplasty (TKA) is a common orthopedic surgery in elderly patients, often requiring effective postoperative pain control to enhance recovery. Conventional locoregional techniques include adductor canal block (ACB) and the iPACK block (infiltration between the Popliteal Artery and Capsule of the Knee). While effective, iPACK may carry infection risks due to its proximity to the surgical field.
The sacral ESP block is a more recent ultrasound-guided technique targeting posterior sacral nerve branches from a remote site, potentially avoiding motor weakness and surgical site complications. Early literature and local clinical experience suggest that combining sacral ESP with ACB may provide comparable analgesia to ACB+iPACK while offering practical and safety advantages.
Study Design:
- Type: Single-center, prospective, observational study
- Setting: Ospedale di Crotone, Italy
- Duration: Maximum of 30 months
- Sample size: 63 patients per group (based on QoR-15 score, with 80% power and α = 0.05)
Population:
- Adults >18 years (ASA I-III), scheduled for unilateral TKA with expected hospitalization >24 hours
- Exclusion: refusal of consent, contraindications to spinal or regional anesthesia, coagulation disorders, severe dementia, ongoing infection, or emergency surgeries
Primary Endpoint:
- Quality of Recovery (QoR-15) score at 24 hours post-surgery (score range 0-150; higher scores indicate better recovery)
Secondary Endpoints:
- Postoperative pain scores (NRS, score range 0-10, higher scores indicate more pain) at rest and movement (0-48 hours)
- Time to first mobilization
- Patient satisfaction (Likert scale)
- Analgesic consumption and time to first request
- Incidence of nausea, vomiting, antiemetic use
- Block-related complications or adverse events
Procedure:
All patients receive spinal anesthesia and multimodal postoperative analgesia (paracetamol, rescue tramadol). Regional blocks are performed under ultrasound guidance in aseptic conditions. ESP is performed at the S2 level with 20 mL ropivacaine 0.375%. ACB and iPACK are also administered per standard protocols.
Data Analysis:
Statistical comparisons between groups will be made using appropriate parametric or non-parametric tests based on variable distribution. Repeated measures will be analyzed using linear mixed-effects models.
Ethics:
The study follows Good Clinical Practice (GCP) and the Declaration of Helsinki. Patients provide written informed consent. Privacy and data confidentiality are ensured.
- Conditions
- Total Knee Anthroplasty, Regional Anesthesia
- Being tested
- Local Anesthetic Injection
- Keywords
- regional anesthesia, total knee arthroplasty
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Local Anesthetic InjectionProcedure or surgery
combination of regional blocks for TKA postoperative analgesia
| Study group | Role | What they receive |
|---|---|---|
| ACB/iPACK | combination of adductor canal block (saphenous) and infiltration between the Popliteal Artery and Capsule of the Knee (iPACK) block Receives: Procedure: Local Anesthetic Injection | |
| ACB/sacral ESP | combination of adductor canal block (saphenous) and sacral erector spinae plane (ESP) block Receives: Procedure: Local Anesthetic Injection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of Recovery (QoR-15) score at 24 hours post-surgery
Quality of Recovery (QoR-15) - score range 0-150 - higher scores indicate better recovery
Measured: at 24 hours post-surgery
Secondary outcomes (4)
Postoperative pain scores (NRS) at rest and movement (0-48 hours)
NRS at rest and movement - score range 0 (no pain) - 10 (the worst pain)
Measured: 0-48 hours from surgery
Time to first mobilization
first patient mobilization - time (hour) of first mobilization
Measured: 0-48 hours
Analgesic consumption (total drug dosage)
Effectiveness of the blocks
Measured: 0-48 hours
Time to first analgesic request (time - hour - of first request)
Duration of the blocks
Measured: 0-48 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2025
- Study start16 Jul 2025
- Primary completionDec 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for Total Knee AnthroplastyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 126 participants (estimated)
Sponsor and investigators
- Lead sponsor
- San Giovanni di Dio Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tommaso Sorrentino, San Giovanni di Dio Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07017400
- Sponsor's protocol ID
- 143/2025
- Acronym
- sacral ESP
- Status last verified
- Aug 2025
- First submitted
- 24 May 2025
- Last updated
- 28 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Marrone F, Fusco P, Paventi S, Pullano C. Combined adductor canal (ACB) and sacral erector spinae plane (S-ESP) blocks for total knee arthroplasty pain in hemophilic arthropathy. Saudi J Anaesth. 2024 Oct-Dec;18(4):565-568. doi: 10.4103/sja.sja_177_24. Epub 2024 Oct 2.
PubMed 39600436Marrone F, Pullano C, Paventi S, Tomei M, Fusco P. A unilateral single level sacral erector spinae plane block for total knee arthroplasty pain. Minerva Anestesiol. 2024 Jul-Aug;90(7-8):707-708. doi: 10.23736/S0375-9393.24.18046-7. Epub 2024 Feb 29. No abstract available.
PubMed 38421355Marrone F, Fusco P, Paventi S, Tomei M, Lolli S, Chironna E, Pullano C. Combined lumbar and sacral erector spinae plane (LS-ESP) block for hip fracture pain and surgery. Minerva Anestesiol. 2024 Jul-Aug;90(7-8):712-714. doi: 10.23736/S0375-9393.24.18093-5. Epub 2024 Apr 24. No abstract available.
PubMed 38656087Marrone F, Paventi S, Tomei M, Failli S, Crecco S, Pullano C. Unilateral sacral erector spinae plane block for hip fracture surgery. Anaesth Rep. 2024 Jan 3;12(1):e12269. doi: 10.1002/anr3.12269. eCollection 2024 Jan-Jun.
PubMed 38187935Satici MH, Tutar MS, Tire Y, Binici O, Cicekler O, Korkmaz E, Pekince O, Kozanhan B. The effect of sacral erector spinae plane block on the quality of recovery after total hip arthroplasty: a prospective, randomized, controlled, multicenter study. Minerva Anestesiol. 2025 Apr;91(4):278-285. doi: 10.23736/S0375-9393.24.18353-8. Epub 2024 Nov 4.
PubMed 39495168Tulgar S, Senturk O, Thomas DT, Deveci U, Ozer Z. A new technique for sensory blockage of posterior branches of sacral nerves: Ultrasound guided sacral erector spinae plane block. J Clin Anesth. 2019 Nov;57:129-130. doi: 10.1016/j.jclinane.2019.04.014. Epub 2019 Apr 15. No abstract available.
PubMed 30999197Lavand'homme PM, Kehlet H, Rawal N, Joshi GP; PROSPECT Working Group of the European Society of Regional Anaesthesia and Pain Therapy (ESRA). Pain management after total knee arthroplasty: PROcedure SPEcific Postoperative Pain ManagemenT recommendations. Eur J Anaesthesiol. 2022 Sep 1;39(9):743-757. doi: 10.1097/EJA.0000000000001691. Epub 2022 Jul 20.
PubMed 35852550
Study at a glance
From the registry record, last updated by the sponsor on 28 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of the Sacral Erector Spinae Plane (ESP) Block in Total Knee Arthroplasty: A Prospective Observational Study
- ClinicalTrials.gov ID
- NCT07017400
- Acronym / sponsor ID
- sacral ESP / 143/2025
- Conditions
- Total Knee Anthroplasty, Regional Anesthesia
- Keywords
- regional anesthesia, total knee arthroplasty
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 126 participants (estimated)
- Lead sponsor
- San Giovanni di Dio HospitalUniversity, hospital or other
- Study start
- 16 Jul 2025 (actual)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 12 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to learn about the analgesic efficacy and postoperative recovery of two locoregional anesthesia combinations in patients > 18 years (ASA I-III), scheduled for unilateral TKA under spinal anesthesia with expected hospitalization > 24 hours:
- ACB + sacral ESP block
- ACB + iPACK block
The main question it aims to answer is: Does the ACB + sacral ESP block combination produce effective postoperative recovery and analgesic effect?
Participants already taking ACB + sacral ESP block as part of their regular peri-operative care for TKA will be followed in the postoperative period for 48 hours.
Detailed description
Total Knee Arthroplasty (TKA) is a common orthopedic surgery in elderly patients, often requiring effective postoperative pain control to enhance recovery. Conventional locoregional techniques include adductor canal block (ACB) and the iPACK block (infiltration between the Popliteal Artery and Capsule of the Knee). While effective, iPACK may carry infection risks due to its proximity to the surgical field.
The sacral ESP block is a more recent ultrasound-guided technique targeting posterior sacral nerve branches from a remote site, potentially avoiding motor weakness and surgical site complications. Early literature and local clinical experience suggest that combining sacral ESP with ACB may provide comparable analgesia to ACB+iPACK while offering practical and safety advantages.
Study Design:
- Type: Single-center, prospective, observational study
- Setting: Ospedale di Crotone, Italy
- Duration: Maximum of 30 months
- Sample size: 63 patients per group (based on QoR-15 score, with 80% power and α = 0.05)
Population:
- Adults >18 years (ASA I-III), scheduled for unilateral TKA with expected hospitalization >24 hours
- Exclusion: refusal of consent, contraindications to spinal or regional anesthesia, coagulation disorders, severe dementia, ongoing infection, or emergency surgeries
Primary Endpoint:
- Quality of Recovery (QoR-15) score at 24 hours post-surgery (score range 0-150; higher scores indicate better recovery)
Secondary Endpoints:
- Postoperative pain scores (NRS, score range 0-10, higher scores indicate more pain) at rest and movement (0-48 hours)
- Time to first mobilization
- Patient satisfaction (Likert scale)
- Analgesic consumption and time to first request
- Incidence of nausea, vomiting, antiemetic use
- Block-related complications or adverse events
Procedure:
All patients receive spinal anesthesia and multimodal postoperative analgesia (paracetamol, rescue tramadol). Regional blocks are performed under ultrasound guidance in aseptic conditions. ESP is performed at the S2 level with 20 mL ropivacaine 0.375%. ACB and iPACK are also administered per standard protocols.
Data Analysis:
Statistical comparisons between groups will be made using appropriate parametric or non-parametric tests based on variable distribution. Repeated measures will be analyzed using linear mixed-effects models.
Ethics:
The study follows Good Clinical Practice (GCP) and the Declaration of Helsinki. Patients provide written informed consent. Privacy and data confidentiality are ensured.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ACB/iPACK | – | Procedure: Local Anesthetic Injectioncombination of adductor canal block (saphenous) and infiltration between the Popliteal Artery and Capsule of the Knee (iPACK) block |
| ACB/sacral ESP | – | Procedure: Local Anesthetic Injectioncombination of adductor canal block (saphenous) and sacral erector spinae plane (ESP) block |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adults >18 years scheduled for unilateral TKA
Key inclusion criteria (3 listed)
- Adults >18 years
- ASA I-III
- scheduled for unilateral TKA with expected hospitalization > 24 hours
Key exclusion criteria (9 listed)
- Refusal of consent
- Local anesthetics allergies
- contraindications to spinal or regional anesthesia
- coagulation disorders
- anticoagulation/antiaggregation medications
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Local Anesthetic Injectioncombination of regional blocks for TKA postoperative analgesia | Procedure or surgery | ACB/iPACK, ACB/sacral ESP |
Primary outcome
Quality of Recovery (QoR-15) score at 24 hours post-surgery
Time frame: at 24 hours post-surgery
Quality of Recovery (QoR-15) - score range 0-150 - higher scores indicate better recovery
4 secondary outcomes
Postoperative pain scores (NRS) at rest and movement (0-48 hours)
Time frame: 0-48 hours from surgery
Time to first mobilization
Time frame: 0-48 hours
Analgesic consumption (total drug dosage)
Time frame: 0-48 hours
Time to first analgesic request (time - hour - of first request)
Time frame: 0-48 hours
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Aug 2025.
- Results publication: PubMed 39600436Marrone F, Fusco P, Paventi S, Pullano C. Combined adductor canal (ACB) and sacral erector spinae plane (S-ESP) blocks for total knee arthroplasty pain in hemophilic arthropathy. Saudi J Anaesth. 2024 Oct-Dec;18(4):565-568. doi: 10.4103/sja.sja_177_24. Epub 2024 Oct 2.
- Results publication: PubMed 38421355Marrone F, Pullano C, Paventi S, Tomei M, Fusco P. A unilateral single level sacral erector spinae plane block for total knee arthroplasty pain. Minerva Anestesiol. 2024 Jul-Aug;90(7-8):707-708. doi: 10.23736/S0375-9393.24.18046-7. Epub 2024 Feb 29. No abstract available.
- Results publication: PubMed 38656087Marrone F, Fusco P, Paventi S, Tomei M, Lolli S, Chironna E, Pullano C. Combined lumbar and sacral erector spinae plane (LS-ESP) block for hip fracture pain and surgery. Minerva Anestesiol. 2024 Jul-Aug;90(7-8):712-714. doi: 10.23736/S0375-9393.24.18093-5. Epub 2024 Apr 24. No abstract available.
- Results publication: PubMed 38187935Marrone F, Paventi S, Tomei M, Failli S, Crecco S, Pullano C. Unilateral sacral erector spinae plane block for hip fracture surgery. Anaesth Rep. 2024 Jan 3;12(1):e12269. doi: 10.1002/anr3.12269. eCollection 2024 Jan-Jun.
- Results publication: PubMed 39495168Satici MH, Tutar MS, Tire Y, Binici O, Cicekler O, Korkmaz E, Pekince O, Kozanhan B. The effect of sacral erector spinae plane block on the quality of recovery after total hip arthroplasty: a prospective, randomized, controlled, multicenter study. Minerva Anestesiol. 2025 Apr;91(4):278-285. doi: 10.23736/S0375-9393.24.18353-8. Epub 2024 Nov 4.
- Results publication: PubMed 30999197Tulgar S, Senturk O, Thomas DT, Deveci U, Ozer Z. A new technique for sensory blockage of posterior branches of sacral nerves: Ultrasound guided sacral erector spinae plane block. J Clin Anesth. 2019 Nov;57:129-130. doi: 10.1016/j.jclinane.2019.04.014. Epub 2019 Apr 15. No abstract available.
- Results publication: PubMed 35852550Lavand'homme PM, Kehlet H, Rawal N, Joshi GP; PROSPECT Working Group of the European Society of Regional Anaesthesia and Pain Therapy (ESRA). Pain management after total knee arthroplasty: PROcedure SPEcific Postoperative Pain ManagemenT recommendations. Eur J Anaesthesiol. 2022 Sep 1;39(9):743-757. doi: 10.1097/EJA.0000000000001691. Epub 2022 Jul 20.
- Individual participant dataSharing planned: Undecided
Related trials for Total Knee Anthroplasty
Not yet recruiting
Ultrasound Guided Combined Adductor Canal, Superior Genicular Nerves and Anterior Femoral Cutaneous Nerves Blocks in Comparison With Periarticular Local Anesthesia Infiltration in Primary Total Knee Arthroplasty
Total Knee Anthroplasty
Not yet recruitingPhase 4
Smart Knee Evaluation of Exparel and Zynrelef in TKA Recovery
Total Knee Anthroplasty
Active, not recruitingObservational study
Impact of Chronic Venous Insufficiency on Outcomes After Total Knee Arthroplasty
Total Knee Anthroplasty, Venous Insufficiency (Chronic)(Peripheral)
Enrolling by invitation
Using a Smart Implantable Device to Compare Early Recovery in Two Different Knee Arthroplasty Approaches
Total Knee Anthroplasty
Recruiting
Evaluation of Choose to Move Replacement Ready (CTM-RR)
Osteoarthritis (OA), Osteoarthritis (OA) of the Hip
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Total Knee Anthroplasty and Regional Anesthesia, run by San Giovanni di Dio Hospital at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Tommaso Sorrentino, Anesthesiology (+393277038017, tommaso.sorrentino@asp.crotone.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of Recovery (QoR-15) score at 24 hours post-surgery (time frame: at 24 hours post-surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07017400, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2025.